As always, the Net trawls our inbox, newsfeed and timeline for the news you may have missed. This week: a European slowdown and a mini-boom in Virginia.
- FierceBiotech reports disappointing 1Q numbers for European biotech VC. The 26 deals that raised 108 million euros represent a 16% decline in the number of deals and a 66% drop in cash. Read more here.
- Is Charlottesville, Virginia poised to become the next biotech hub? With changes in the law to encourage entrepreneurship and a thriving base of 35 biotech companies, many people think so. Find out more in these two stories, here and here.